October 28, 2022
October 28, 2022 —
In animal models, UC San Diego researchers found that intensive physical therapy in tandem with implanted neural stem cells increased tissue growth, repair and functionality in spinal cord injuries more than those treatments alone.
October 31, 2022
October 31, 2022 —
UC San Diego researchers and others report that more than one-third of the COVID-19 patients who did not receive any treatment experienced complete resolution of symptoms for at least two consecutive days, but then subsequently reported a return of symptoms.
November 10, 2022
November 10, 2022 —
An international symposium November 17-18, 2022 at UC San Diego will discuss current clinical trials using gene therapy, here and abroad.
November 17, 2022
November 17, 2022 —
UC San Diego researchers expand and deepen understanding of how genetic aberrations fuel human papilloma virus-negative head and neck cancers and, potentially, provide paths to further refinement and improvement of immune checkpoint inhibitors for HPV-negative head and neck cancers.
November 17, 2022
November 17, 2022 —
Engineers and physicians at UC San Diego have developed a device to non-invasively measure cervical nerve activity in humans, a new tool they say could potentially inform and improve treatments for patients with sepsis or post-traumatic stress disorder.
December 15, 2022
December 15, 2022 —
Researchers at UC San Diego provide new insights into the pathology of limbic predominate age-related TDP-43 encephalopathy, which mimics Alzheimer’s, making it very difficult to identify in living patients.
January 18, 2023
January 18, 2023 —
Five years after the deadliest and most destructive wildfire in California history, UC San Diego researchers document persistent differences in cognitive function among survivors.
January 31, 2023
January 31, 2023 —
The evolution of clinical trials is accelerating, driven by emerging technologies, social imperatives and the next public health crisis.
March 16, 2023
March 16, 2023 —
UC San Diego researchers use a DNA designer drug to restore key protein levels in motor neurons, delaying paralysis in a mouse model of ALS.
April 3, 2023
April 3, 2023 —
The National Institute of Allergy and Infectious Diseases has awarded a five-year, $15.45 million grant to the San Diego Center for AIDS Research at UC San Diego, renewing support that extends back to an original establishing grant in 1994 at the height of the AIDS epidemic.